Revenue

Debuting at CES 2026, ANTHBOT's new robotic mowers do more than just cut grass—they sweep, collect, and mulch, challenging industry giants.

A 2.9 MEUR deal for GomSpace to design lunar spacecraft for a major North American firm signals a new era for small satellites in deep space exploration.

Radiant Ridge Energy's new 40MW project in Alberta bypasses the grid, converting natural gas directly into power for the booming AI and data industry.

As 2026 begins, the crypto market sees a split personality: a wild memecoin surge alongside a steady, tech-driven recovery in the AI sector.

With a 70-year legacy, Godrej targets the Middle East's booming market at Intersec 2026, showcasing smart, certified, and sustainable security solutions.

Global Capability Centers are shedding their cost-center image, embracing AI-first models and expanding into new Indian cities to become strategic innovators.

The semiconductor giant's stellar revenue, driven by a 19% surge in its core packaging business, confirms strong demand for AI and advanced tech.

A new AI-designed vaccine, TG4050, has prevented relapse in all head and neck cancer patients in a key trial, signaling a breakthrough in personalized medicine.

A major pharma giant is betting on artificial intelligence to accelerate cancer drug discovery, a move that could reshape the future of oncology treatment.

At CES 2026, an awards ceremony marks two decades of upheaval, chronicling China's rise from follower to leader in the global electronics industry.

Belgian biotech MRM Health gets the green light for a Phase 2b trial of MH002, a novel 'living drug' aimed at revolutionizing ulcerative colitis care.

AS Tallinna Sadam reports robust 2025 results, with a major jump in liquid bulk cargo and a strong rebound in cruise tourism signaling regional recovery.

Swiss lab automation giant Tecan shows signs of a turnaround with robust H2 2025 orders, betting on AI to navigate a recovering life sciences market.

As Valneva meets investors, all eyes are on its pivotal Lyme disease vaccine data, a potential game-changer for public health and the company's future.

A new report reveals shifting consumer demands for THCA flower, as the booming market grapples with quality standards and a complex regulatory future.

Chery Australia's new campaign does more than sell cars; it aims to drive tourism to regional Australia and redefine the classic family road trip.

The smartphone giant joins the VVC Advance patent pool, a key move poised to speed up the adoption of next-gen video codecs for consumers worldwide.

Ventyx Biosciences is under investigation for misleading investors after a trial delay caused a 15% stock drop, even as a pharma giant moves to acquire it.

Boston's Moody Aldrich Partners commits $600M to London's SCIO Capital, a major validation of specialized asset-backed lending in Europe's booming market.

The P&C insurance tech leader leverages its strong cash position for a massive buyback, signaling confidence amid its successful cloud transformation.